Context: Few studies compare Alzheimer disease (AD) incidence among black and white subjects.
L
ARGE-SCALE STUDIES of Alzheimer disease (AD) and the effects of the apolipoprotein E (APOE) ⑀4 allele on risk are uncommon among the black population in the United States. [1] [2] [3] [4] After its initialdescription, 5 thefindingthattheAPOE ⑀4 allele is associated with increased risk of AD has been replicated in many white populations, 6 ,7 but studies 1, 8 of populations with a large fraction of American or African black subjects have usually suggested less effect of the APOE ⑀4 allele on disease risk. Therefore, we studied APOE and the risk of incident AD among black and white subjects in a geographically defined population.
METHODS

THE STUDY COMMUNITY AND STUDY DESIGN
The study was conducted in a geographically defined community of 3 neighborhoods in Chicago, Ill-Morgan Park, Washington Heights, and Beverly. A census enumerated 64 911 residents; 8509 (13.1%) were aged 65 years or older, 432 died, and 251 left the community. Of the remaining 7826 residents, 6158 (78.7% overall; 80.5% of the blacks, 74.6% of the whites) participated. Institutionalized persons were eligible, but of 3 nursing homes in the community 1 declined participation. Data were collected in cycles of approximately 3 years; each consisting of an in-home interview of all participants and clinical evaluation of a random, stratified sample. The baseline cycle measured disease prevalence, provided risk factor data before incident disease onset, and identified a cohort of 3838 persons free of AD; 729 persons were sampled for baseline clinical evaluation. 12 Judgment of Line Orientation, 13 Complex Ideational Material, 14 Number Comparison, 15 Digit Ordering, 16 Standard Progressive Matrices, 17 and National Adult Reading Test. 18 A neuropsychologist (R.S.W.), blinded to age, sex, race, and clinical data other than educational level, occupation, and information about sensory or motor deficits, summarized impairment in each of 5 domains (orientation, attention, memory, language, and perception). Structured neurological examination and medical history were by specially trained nurse clinicians; a board-certified neurologist (D.A.B., N.A. or J.S.) reviewed all data and reexamined each participant. Brain magnetic resonance imaging was restricted to persons with evidence of dementia and uncertainty as to whether a stroke had occurred or its relation to dementia.
Diagnosis of dementia required loss of cognitive function by the neurologist's assessment and impairment in 2 or more functions on the cognitive performance tests. This diagnosis was made using criteria of the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association for probable AD, 19 except that persons who met these criteria and had another condition impairing cognition were retained. Vascular dementia was diagnosed by criteria of the National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences International Workshop. 20 Race was measured using US census questions. Education was measured by years of formal schooling. Apolipoprotein E genotyping was done, blinded to all other study data, using methods adapted from Hixson and Vernier 21 and primers described by Wenham et al. 22 The study was approved by the Rush-Presbyterian-St Luke's Medical Center institutional review board.
STATISTICAL ANALYSES
Incidence in the community population was estimated from the sample in 3 steps. First, a logistic regression model provided smoothed estimates of incidence in each stratum, 23 taking advantage of the information in adjacent strata. Second, an empirical Bayes approach 24 was used to combine this smoothed estimate with the observed crude incidence for that stratum, relying more heavily on the observed proportions if there was a large sample in the stratum or evidence of deviation from the model. Third, the empirical Bayes estimates from the strata were combined using the sampling weights to estimate incidence in the population. 24 The SE estimates were obtained by bootstrap resampling. 25 Analytic procedures were carried out using SAS software. 26 The same procedures were used for incidence estimates within age and race population subgroups, and for incidence estimates of vascular dementia. The associations of age, sex, race, education, and APOE genotype to AD incidence were assessed by fitting logistic regression models adjusted for the complex sampling design. All models were validated using graphical and analytic techniques to check for violations of model assumptions and for interactions.
RESULTS
INCIDENCE OF AD
The random sample initially free of AD had 842 persons, but 7 (0.09%) supplied insufficient information for diag- sex, race, education, and the APOE ⑀4 allele on disease incidence were examined ( Table 2 ) using logistic regression models that included the interval from baseline evaluation to evaluation for incident disease for each person. The odds ratio of 1.16 (95% CI, 1.11-1.22) for age indicates that age was strongly associated with the risk of incident AD. Sex had little or no effect on risk. Education was a marker for a lower risk of developing AD. The odds ratio of 0.88 (95% CI, 0.79-0.97) indicated that each additional year of formal schooling was associated with approximately a 12% decrease in the incidence of AD. The effects of race on incidence of AD were less clear. In analyses including age, education, the APOE ⑀4 allele, and the interaction between APOE and race, there was a nonsignificant increase in odds of disease for blacks, 1.84 (95% CI, 0.73-4.66). This analysis, because of the term for interaction between APOE and race, compares risk among blacks and whites without the APOE ⑀4 allele. If one omits APOE ⑀4 and its interaction with race, the odds ratio for blacks decreases to 1.28 (95% CI, 0.54-2.98), as all blacks are then compared with all whites regardless of APOE ⑀4, which increases the risk among whites (see below).
APOE ⑀4 ALLELE AND AD
Apolipoprotein E genotype was determined for 818 persons (98.0%): 42.1% of blacks had at least 1 APOE ⑀4 allele compared with 27.1% of whites in weighted analyses (PϽ.01) ( Table 3) . Effects of the APOE ⑀4 allele on risk of developing AD differed markedly by race. The analysis for the entire population (Table 2) includes terms for blacks and for interaction between the black race and the presence of 1 or more APOE ⑀4 alleles. Thus, the coefficient labeled "Any ⑀4 allele" represents the effect of this allele among whites, for whom presence of 1 or more APOE ⑀4 alleles was associated with a substantial increase in risk. The coefficient for interaction of APOE ⑀4 allele status and black race is of borderline significance and approximately equal to the "Any ⑀4 allele" term, but opposite in direction, indicating that the allele had no effect on risk among blacks. This is confirmed by separate analyses for each race ( Table 2 ). The APOE ⑀4 allele is associated with a 2.7-fold increase in risk in the analysis limited to whites, odds ratio 2.73 (95% CI, 1.40-5.32), and with little increase in risk in the analysis limited to blacks (odds ratio, 1.02; 95% CI, 0.39-2.68). The effect of APOE ⑀4 status did not seem to vary with age (ageϫany APOE ⑀4 interaction; odds ratio, 0.97; 95% CI, 0.90-1.06), or sex (male sexϫany APOE ⑀4 interaction; odds ratio, 1.24; 95% CI, 0.35-4.35). Repeating analyses with individual genotypes distinguished and interaction of each genotype with black race, and considering AD as an exclusive diagnosis, did not change risk factor results substantially. (Results not shown.)
INCIDENCE OF VASCULAR DEMENTIA
Vascular dementia was much less common than AD. The annual incidence of probable vascular dementia was 0.28% (95% CI, 0.00%-2.72%) overall, 0.30% (95% CI, 0.00%-3.03%) among blacks and 0.26% (95% CI, 0.00%-2.39%) among whites. Other dementing conditions were uncommon; 13 persons had incident dementia due to another condition.
COMMENT
These results suggest the effects of the APOE ⑀4 allele on the risk of incident AD may differ strongly for black Americans and white Americans. The presence of an APOE ⑀4 allele was associated with a 2.7-fold increase in risk for whites, but with no increased risk for blacks. Most studies in white populations have found that the APOE ⑀4 allele is associated with strongly increased risk of AD. [5] [6] [7] Although the relation has been less extensively examined in black populations, the results of this study are generally consistent with previous studies. Tang et al 1 found that, compared with persons with the APOE ⑀3/⑀3 genotype, having 1 or more copies of the APOE ⑀4 allele increased the risk of AD 2.5-fold among whites but not among blacks. Sahota et al 8 found an odds ratio of 4.83 among African Americans homozygous for the APOE ⑀4 allele and of 1.20 among those with the APOE ⑀3/⑀4 genotype.
Reasons underlying a different effect on risk by race are uncertain. One possibility is chance alone, but this seems unlikely as the result is consistent with prior studies and the sample size is large. Another is linkage disequilibrium between APOE and another locus with an allele actually responsible for the risk and uncommon in populations of African origin. Another is the diminishing effect of APOE with age, with persons in this study too old to show an effect. We found no diminution of the APOE ⑀4 effect with age, and this diminution was also not evident in some other population studies. 7 Another is interaction between the APOE ⑀4 allele and some unknown environmental or genetic factor that is distributed differently across the 2 races.
The study leaves unclear whether being black, in itself, is associated with an increased risk of AD, although the nonsignificant odds ratio of 1.84 suggests it may be. Black Americans have, on average, higher levels of vascular risk factors, especially elevated blood pressure, than whites, which may increase risk of AD. 27 Results have varied among the few previous studies of AD in biracial US populations. [1] [2] [3] [4] Direct comparisons of population studies of AD are hazardous, as mild disease that is difficult to separate from normality is common, and even minor differences in methods can result in large differences in estimates. The East Boston Study was similar in approach to this study, and incidence estimates among whites seem comparable. 28 The estimates for blacks from this study are higher than those from the Indianapolis-Ibadan study, 3 but this likely reflects differences in study methods, not actual differences in disease incidence.
Strengths of this study include large size, incidence data to make comparison across groups with different cultural experiences, structured uniform procedures, and accepted criteria for disease. Weaknesses include indirect assessment to initially identify most of the disease-free cohort, so that a small proportion of this cohort really may have had preexisting disease. Participation in the baseline population interview was slightly higher for blacks (80.5%, compared with 74.6% for whites), but participation in the clinical evaluation sample measuring incident disease was higher for whites (81.9%, compared with 67.6% for blacks). Overall this pattern resulted in similar participation by race.
The results of this and previous studies suggest that the effect of the APOE ⑀4 allele may differ substantially across major ethnic lines. The implications of this finding deserve further investigation, especially examination of genetic and environmental differences between the 2 groups.
